다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
ReShape Lifesciences Inc (RSLS)
ReShape Lifesciences Inc (RSLS) 뉴스

RSLS

ReShape Lifesciences (RSLS)

ReShape Lifesciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RSLS

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:50	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/05/16	05:05	GlobeNewswire Inc.	ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/05/14	21:31	GlobeNewswire Inc.	ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/04/02	05:05	GlobeNewswire Inc.	ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/03/28	21:31	GlobeNewswire Inc.	ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/03/04	22:31	GlobeNewswire Inc.	ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/02/27	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/02/22	22:31	GlobeNewswire Inc.	ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/24	22:31	GlobeNewswire Inc.	ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/19	06:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/17	08:11	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RSLS	ReShape Lifesciences Inc
2024/01/06	06:14	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/12/20	22:31	GlobeNewswire Inc.	ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/12/13	06:05	GlobeNewswire Inc.	ReShape Lifesciences® Receives FDA PMA Supplement Approval for its Next-Generation Lap-Band® 2.0 FLEX	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/30	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/21	22:06	GlobeNewswire Inc.	ReShape Lifesciences® Enters into Warrant Exercise Transaction for $1.2 Million in Gross Proceeds	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/09	06:05	GlobeNewswire Inc.	ReShape Lifesciences® Reports Third Quarter Ended September 30, 2023 Financial Results and 2024 Cost Reduction Plan	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/11/06	22:31	GlobeNewswire Inc.	ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2023 and Provide Corporate Update	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/10/14	05:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/10/06	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/10/03	22:23	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/30	01:30	GlobeNewswire Inc.	ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/28	06:30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/23	05:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/22	21:31	GlobeNewswire Inc.	ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/21	21:31	GlobeNewswire Inc.	ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/19	21:31	GlobeNewswire Inc.	ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/09/14	21:31	GlobeNewswire Inc.	ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/08/26	05:41	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:RSLS	ReShape Lifesciences Inc
2023/08/08	06:26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RSLS	ReShape Lifesciences Inc

검색 관련기사 보기:NASDAQ:RSLS

1 2 3 4 5 6 다음 >>

Strasbaugh (CE)

Aristocrat Leisure

BPCE International bonds...

Ammsci Newenrgy

Barclays 2.291%

FTSE Athex Energy & Util...

Holders Technology

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관